EMD-24696

Single-particle
3.3 Å
EMD-24696
3D View Gallery
Deposition: 16/08/2021
Map released: 24/08/2022
Last modified: 04/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-24696
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7ru4 summary report (pdf.gz) Map and 7ru4 FULL report (pdf.gz)
EMICSS annotations (xml)

CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement)

EMD-24696

Single-particle
3.3 Å
EMD-24696
3D View Gallery
Deposition: 16/08/2021
Map released: 24/08/2022
Last modified: 04/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: CC6.33 IgG in complex with SARS-2-CoV-6P-Mut7 S protein
Fitted models: 7ru4

Deposition Authors: Ozorowski G, Turner HL, Ward AB
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways.
Zhao F , Keating C, Ozorowski G, Shaabani N, Francino-Urdaniz IM, Barman S, Limbo O , Burns A, Zhou P , Ricciardi MJ, Woehl J , Tran Q, Turner HL, Peng L, Huang D, Nemazee D, Andrabi R, Sok D, Teijaro JR, Whitehead TA, Ward AB, Burton DR, Jardine JG
(2022) iScience , 25 , 104914 - 104914
PUBMED: 35971553
DOI: doi:10.1016/j.isci.2022.104914
ISSN: 2589-0042